Gene delivery system based on highly specific recognition of surface-vimentin with N-acetylglucosamine immobilized polyethylenimine

Biomaterials

Volumn 32, Issue 13, 2011, Pages 3471-3480

  Kim, Sun Jung ^a   Ise, Hirohiko ^a   Goto, Mitsuaki ^b   Komura, Kenta ^a   Cho, Chong Su ^c   Akaike, Toshihiro ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b Celagix Res Ltd   (Japan)

^c Seoul National University   (South Korea)

Author keywords

Gene delivery; N Acetylglucosamine; Polyethlylenimine; Vimentin

Indexed keywords

BINDING LECTIN; CELL SURFACES; DRUG-DELIVERY SYSTEMS; GENE DELIVERY; GENE-DELIVERY SYSTEMS; GREEN FLUORESCENT PROTEIN; HELA CELL; INTERMEDIATE FILAMENTS; LUCIFERASE GENES; MICROSCOPIC ANALYSIS; N-ACETYLGLUCOSAMINE; POLYETHLYLENIMINE; POLYETHYLENIMINES; SPECIFIC RECOGNITION; TUMOR CELLS; VIMENTIN;

CARBOHYDRATES; CELL CULTURE; CELL MEMBRANES; GENE THERAPY; GENE TRANSFER; HISTOLOGY;

GENE EXPRESSION;

DESMIN; GREEN FLUORESCENT PROTEIN; LUCIFERASE; N ACETYLGLUCOSAMINE; POLYETHYLENEIMINE; VIMENTIN;

ARTICLE; CELL SURFACE; CONFOCAL MICROSCOPY; GENE DELIVERY SYSTEM; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ACETYLGLUCOSAMINE; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; POLYETHYLENEIMINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VIMENTIN;

EID: 79952006024     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.062     Document Type: Article

References (43)

1. Langer R. Drug delivery and targeting. Nature 1998, 30(392):5-10.
2. Yamazaki N., Kojima S., Bovin N.V., André S., Gabius S., Gabius H.J. Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev 2000, 30(43):225-244.
3. Wall D.A., Wilson G., Hubbard A.L. The galactose-specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell 1980, 21:79-93.
4. Zanta M.A., Boussif O., Adib A., Behr J.P. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997, 8:839-844.
5. Cook S.E., Park I.K., Kim E.M., Jeong H.J., Park T.G., Choi Y.J., et al. Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier. J Control Release 2005, 105:151-163.
6. Hashida M., Takemura S., Nishikawa M., Takakura Y. Targeted delivery of plasmid DNA complexed with galactosylated poly(l-lysine). J Control Release 1998, 53:301-310.
7. Kawakami S., Fumoto S., Nishikawa M., Yamashita F., Hashida M. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm Res 2000, 17:306-313.
8. Tamaki S., Ueno T., Torimura T., Sata M., Tanikawa K. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology 1996, 111:1049-1057.
9. Takei Y., Maruyama A., Ferdous A., Nishimura Y., Kawano S., Ikejima K., et al. Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J 2004, 18:699-701.
10. Platt V.M., Szoka F.C. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm 2008, 5:474-486.
11. Varghese O.P., Sun W., Hilborn J., Ossipov D.A. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: A hydrogel linked prodrug approach. J Am Chem Soc 2009, 131:8781-8783.
12. Diebold S.S., Kursa M., Wagner E., Cotten M., Zenke M. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 1999, 274:19087-19094.
13. Higuchi Y., Nishikawa M., Kawakami S., Yamashita F., Hashida M. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. Int J Pharm 2004, 287:147-154.
14. Kobayashi S., Ise H., Takahashi M., Goto M., Akaike T., Ikeda U. Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy. Biomaterials 2009, 30:574-582.
15. Ise H., Kobayashi S., Goto M., Sato T., Kawakubo M., Takahashi M., et al. Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces. Glycobiology 2010, 20:843-864.
16. Steinert P.M., Jones J.C., Goldman R.D. Intermediate filaments. J Cell Biol 1984, 99:22-27.
17. Herrmann H., Aebi U. Intermediate filaments and their associates: multitalented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 2000, 12:79-90.
18. Aso S., Ise H., Takahashi M., Kobayashi S., Morimoto H., Izawa A., et al. Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro. J Control Release 2007, 122:189-198.
19. Varmus H. Retroviruses, Sci 1988, 240:1427-1435.
20. Flotte T.R., Carter B.J. Adeno-associated virus vectors for gene therapy. Gene Ther 1995, 6:357-362.
21. Huang L., Viroonchatapan E. Introduction. Non-viral vector for gene therapy 1999, 3-22. Academic Press, NewYork. L. Huang, M. Wagner (Eds.).
22. Woodrow K.A., Cu Y., Booth C.J., Saucier-Sawyer J.K., Wood M.J., Saltzman W.M. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 2009, 8:526-533.
23. Erbacher P., Zou S., Bettinger T., Steffan A.M., Remy J.S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998, 15:1332-1339.
24. Read M.L., Etrych T., Ulbrich K., Seymour L.W. Characterisation of the binding interaction between poly(l-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors. FEBS Lett 1999, 461:96-100.
25. Malik N., Wiwattanapatapee R., Klopsch R., Lorenz K., Frey H., Weener J.W., et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 2000, 65:133-148.
26. Liu Y., Liggitt D., Zhong W., Tu G., Gaensler K., Debs R. Cationic liposome-mediated intravenous gene delivery. J Biol Chem 1995, 270:24864-24870.
27. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999, 60:149-160.
28. Klemm A.R., Young D., Lloyd J.B. Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem Pharmacol 1998, 56:41-46.
29. Guo W., Lee R.L. Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS PharmSci 1999, 1:E19.
30. Kim S.H., Jeong J.H., Cho K.C., Kim S.W., Park T.G. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release 2005, 104(1):223-232.
31. Jeong J.H., Kim S.H., Kim S.W., Park T.G. In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles. J Biomater Sci Polym 2005, 16:1409-1419.
32. Jiang H.L., Kwon J.T., Kim E.M., Kim Y.K., Arote R., Jere D., et al. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. J Control Release 2008, 131:150-157.
33. Jiang H.L., Kim Y.K., Arote R., Jere D., Quan J.S., Yu J.H., et al. Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting. Int J Pharm 2009, 375:133-139.
34. Kunath K., Merdan T., Hegener O., Häberlein H., Kissel T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 2003, 5:588-599.
35. Kursa M., Walker G.F., Roessler V., Ogris M., Roedl W., Kircheis R., et al. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem 2003, 14:222-231.
36. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997, 4:409-418.
37. Blessing T., Kursa M., Holzhauser R., Kircheis R., Wagner E. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug Chem 2001, 12:529-537.
38. Lee H., Kim T.H., Park T.G. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J Control Release 2002, 83:109-119.
39. Kunath K., von Harpe A., Fischer D., Kissel T. Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Release 2003, 88:159-172.
40. Fischer D., Bieber T., Li Y., Elsässer H.P., Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999, 16:1273-1279.
41. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784.
42. Tsuji T., Ibaragi S., Hu G.F. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009, 69:7135-7139.
43. Kollen W.J., Midoux P., Erbacher P., Yip A., Roche A.C., Monsigny M., et al. Gluconoylated and glycosylated polylysines as vectors for gene transfer into cystic fibrosis airway epithelial cells. Hum Gene Ther 1996, 7:1577-1586.